ÖGP 2021
Prevalence of restrictive lung function and clinical characteristics in a generalpopulation:
the LEAD (Lung, hEart, sociAl, boDy) study
C. Schiffers, E. F. M. Wouters, M.-K. Breyer, M. Veselinovic, T. Mraz, G. Kohlböck, O. C. Burghuber, S. Hartl, B. Lamprecht, R. Breyer-Kohansal
Influence of body composition on lung function in children and adolescents
A. Ofenheimer
Validation of the 2021 GLI reference equations for static lung volumes in a general European cohort
T. Mraz, M. Veselinovic, A. Ofenheimer, M.-K. Breyer, S. Hartl, O. C Burghuber, B. G. Cooper, A. Zacharasiewicz, B. Lamprecht, S. Stanojevic, R. Breyer-Kohansal
COVID-19 and Weaning
S. Hartl
Oscillometry and lung function testing
E. F. M. Wouters
ERS 2021
Appendicular lean mass – a driver of low lung function in children?
Data from the population-based LEAD (Lung, hEart, sociAl, boDy) cohort
A. Ofenheimer, R. Breyer-Kohansal, S. Hartl, O. C. Burghuber, F. Krach, F. Franssen, E. F. M Wouters, M.-K. Breyer
Late Breaking Abstract – Validation of the 2021 GLI reference equations for static lung volumes in a general
European cohort
T. Mraz, M. Veselinovic, A. Ofenheimer, M.-K. Breyer, S. Hartl, O. C. Burghuber, B. G. Cooper, A. Zacharasiewicz, B. Lamprecht, S. Stanojevic, R. Breyer-Kohansal
Aero-allergen sensitization in a general population: data from the LEAD population cohort study
F. Kölli, M.-K. Breyer, S. Hartl , G. Kohlböck, O. C. Burghuber , W. Pohl , T. Sigsgaard, E. F. M. Wouters, R. Breyer-Kohansal
ÖGP 2020
Prevalence of positive skin prick test and associated risk factors within a general population –
data from the LEAD Study.
F. Kölli, M.-K. Breyer, S. Hartl, O. C. Burghuber, A. Schrott, E. F. M. Wouters, R. Breyer-Kohansal
SARS-CoV-2-specific Antibody Seroprevalence in a General Population – The Viennese LEAD COVID-19 Study.
M. Fiedler, M.-K. Breyer, R. Breyer-Kohansal, S. Hartl, M. Kundi, L. Weseslindtner, K. Stiasny, E. Puchhammer-Stöckl, M. Födinger, E. F. M. Wouters, O. C. Burghuber.
Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment.
A. Ofenheimer, R. Breyer-Kohansal, S. Hartl, O. C. Burghuber, J. Altziebler, A. Schrott, F. M. Franssen, E. F. Wouters, J. Harreiter, A. Kautzky-Willer, M. K. Breyer
ERS 2020
Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment.
A. Ofenheimer, R. Breyer-Kohansal, S. Hartl, O. C. Burghuber, J. Altziebler, A. Schrott, F. M. Franssen, E. F. Wouters, J. Harreiter, A. Kautzky-Willer, M. K. Breyer
ATS 2019
Revised Blood Eosinophil Ranges in A Healthy General Population – Data from The LEAD Study.
A. Ofenheimer, S. Hartl, R. Breyer-Kohansal, M. Urban, M.-K. Breyer, A. Schrott, M. Studnicka, O. C. Burghuber
ERS 2019
The prevalence of restrictive lung function in a general population obtained by spirometry and bodyplethysmography – data from the LEAD Study.
R. Breyer-Kohansal, M.-K.Breyer, O. C. Burghuber, A. Horner, B. Lamprecht, A. Ofenheimer, A. Schrott, S. Hartl
Prevalence of abnormal lung function and age-dependent risk factors in the general population.
A. Ofenheimer, M. K. Breyer, S. Hartl, O. C. Burghuber, A. Agusti R. Faner, A. Schrott, M. Urban, R. Breyer-Kohansal
Prevalence and characteristics of chronic cough in a general population study.
H. Abozid, S. Hartl, R. Breyer-Kohansal, M. K. Breyer, A. Ofenheimer, A. Schrott, O. C. Burghuber
ÖGP 2019
Microvascular coronary perfusion and hyperinflation in COPD – The Austrian LEAD Study.
F. Valach, M.-K. Breyer, R. Breyer-Kohansal, A. Ofenheimer, S. Hartl, O.C. Burghuber, M. Urban
Discordance of asthma therapy with the new GINA Guideline 2019: real world data from the LEAD Study.
T. Mraz, O.C. Burghuber, M-K. Breyer, A. Schrott, S. Hartl, R. Breyer-Kohansal
Prevalence of abnormal lung function and age-dependent risk factors in the general population.
A. Ofenheimer, M. K. Breyer, S. Hartl, O. C. Burghuber, A. Agusti R. Faner, A. Schrott, M. Urban, R. Breyer-Kohansal
Prevalence and characteristics of chronic cough in a general population study.
H. Abozid, S. Hartl, R. Breyer-Kohansal, M. K. Breyer, A. Ofenheimer, A. Schrott, O. C. Burghuber
EASD 2019
Marked differences in prediabetes and diabetes associated comorbidities between men and women – epidemiological results from a general population-based cohort aged 6-80 years –
the LEAD (Lung, hEart, sociAl, boDy) Study.
A. Ofenheimer, R. Breyer-Kohansal, S. Hartl, M. Urban, O.C. Burguber, J. Altziebler, A. Schrott, F.M.E Franssen, E.F.M. Wouters, M. Studnicka, J. Harreiter, A. Kautzky-Willer, M.-K. Breyer
ERS 2018
Risk factors of abnormal lung function in children and adolescents –
data from the LEAD (Lung, hEart, sociAl, boDy) Study.
A. Ofenheimer, M.-K. Breyer, M. Urban, S. Hartl, O.C. Burghuber, A. Schrott, R. Breyer-Kohansal
Microvascular coronary perfusion and hyperinflation in COPD –
data from the LEAD (Lung, hEart, sociAl, boDy) Study.
M. Urban, M.-K. Breyer, R. Breyer-Kohansal, A. Schrott, A. Ofenheimer, S. Hartl, O.C. Burghuber
ÖGP 2018
Risk factors of abnormal lung function in children and adolescents identified by cluster analysis of an unbiased systemic network approach within a general population.
A. Ofenheimer, M.-K. Breyer, S. Hartl, O.C. Burghuber, A. Schrott, M. Urban, R. Breyer-Kohansal
ÖGIM 2018
Determinants of arterial stiffness in the Austrian general population – data from the LEAD (Lung, hEart, sociAl, boDy) Study.
E. Margulies, M. Urban, R. Breyer-Kohansal, M.-K. Breyer, O.C. Burghuber